Trends in age and antithrombotic therapy in patients who underwent transurethral resection of bladder tumor and perioperative complications
The age of patients receiving antithrombotic drugs has increased, and antithrombotic drug types have changed among those who underwent TURBT. Further attention to hemorrhagic and lethal cardiocirculatory complications after TURBT will be required in a super-aged society.
Authors
- Haruka Takagi (ORCID: https://orcid.org/0000-0002-4060-8171)
- Ryoken Tsunekawa
- Masaya Nagabuchi
- Takeya Kitta (ORCID: https://orcid.org/0000-0003-2870-9225)
- Naoki Wada (ORCID: https://orcid.org/0000-0002-9587-6798)
- Hidehiro Κakizaki (ORCID: https://orcid.org/0000-0002-4340-9426)
- Tsubasa Hatakeyama
- Shin Kobayashi (ORCID: https://orcid.org/0000-0001-5896-4548)
Institutions
- Asahikawa Medical University (JP)
Publication Details
- Journal
- International Journal of Urology
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1111/iju.15684
- Citations
- 1
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.01